Regulatory GSK claims FDA okay for first oral carbapenem antibiotic PharmaphorumGSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi.Infectious DiseaseRead full story pharminent June 18, 2026 (Last updated: June 19, 2026) Pharmaphorum GSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi. Infectious Disease Read full story Post navigation Previous: LG AI Research and D&D Pharmatech sign agreement for oral peptide drugsNext: Cardio biotech Kardigan binds off $400M upsized IPO Related Stories Regulatory Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa pharminent August 20, 2026 Regulatory Regeneron wins FDA approval to challenge Ipsen for rare bone disease market pharminent August 20, 2026 Regulatory FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy pharminent August 20, 2026
